The whole underlying theme here is this stigma and bias of not recognizing obesity as a disease like we do cancer and diabetes and everything else, says Florencia Halperin, an endocrinologist and chief medical officer at Form Health, an online medical weight loss clinic, For cancer, you would never have an employer who says, We're not covering this. Amanda Bonello, founder and CEO of the GLP-1 Collective, a nonprofit organization aiming to help patients access these medications, is not surprised at the lengths patients are going to
Rahul Mehrotra, Chief - NIC & Clinical Cardiology, Artemis Hospitals Cholesterol can lead to heart blockage: Doctor shares early prevention tips No foul play, but medical sensitivity under scanner Police have found no foul play so far
With more and more people using GLP-1 receptor agonists for diabetes and weight management, healthcare providers are becoming more aware of ways both positive and negative these medications impact the body
Free Worldwide Shipping on Orders $100+ Free Returns & Exchanges in the U.S
The goal isnt to rush to the highest dose as soon as possible, but rather to find the dose that helps support the best progress while keeping treatment manageable